JP2007518760A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007518760A5 JP2007518760A5 JP2006549999A JP2006549999A JP2007518760A5 JP 2007518760 A5 JP2007518760 A5 JP 2007518760A5 JP 2006549999 A JP2006549999 A JP 2006549999A JP 2006549999 A JP2006549999 A JP 2006549999A JP 2007518760 A5 JP2007518760 A5 JP 2007518760A5
- Authority
- JP
- Japan
- Prior art keywords
- dry weight
- weight basis
- pharmaceutically acceptable
- tablet
- dpp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53770604P | 2004-01-20 | 2004-01-20 | |
| US60/537,706 | 2004-01-20 | ||
| US60427404P | 2004-08-25 | 2004-08-25 | |
| US60/604,274 | 2004-08-25 | ||
| PCT/EP2005/000400 WO2005067976A2 (en) | 2004-01-20 | 2005-01-17 | Direct compression formulation and process |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012107450A Division JP5739835B2 (ja) | 2004-01-20 | 2012-05-09 | 直接圧縮製剤および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007518760A JP2007518760A (ja) | 2007-07-12 |
| JP2007518760A5 true JP2007518760A5 (https=) | 2008-03-06 |
| JP5122144B2 JP5122144B2 (ja) | 2013-01-16 |
Family
ID=34798877
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006549999A Expired - Lifetime JP5122144B2 (ja) | 2004-01-20 | 2005-01-17 | 直接圧縮製剤および方法 |
| JP2012107450A Expired - Lifetime JP5739835B2 (ja) | 2004-01-20 | 2012-05-09 | 直接圧縮製剤および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012107450A Expired - Lifetime JP5739835B2 (ja) | 2004-01-20 | 2012-05-09 | 直接圧縮製剤および方法 |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US20080038341A1 (https=) |
| EP (5) | EP3366283B1 (https=) |
| JP (2) | JP5122144B2 (https=) |
| KR (1) | KR101259645B1 (https=) |
| AR (1) | AR049000A1 (https=) |
| AU (1) | AU2005205055B2 (https=) |
| BR (3) | BR122018014389B1 (https=) |
| CA (1) | CA2552569C (https=) |
| CY (3) | CY1110522T1 (https=) |
| DE (1) | DE602005015421D1 (https=) |
| DK (3) | DK1715893T3 (https=) |
| EC (3) | ECSP066707A (https=) |
| ES (4) | ES2940341T3 (https=) |
| HR (2) | HRP20211766T1 (https=) |
| HU (2) | HUE056586T2 (https=) |
| IL (1) | IL176831A0 (https=) |
| LT (2) | LT3023095T (https=) |
| MA (1) | MA28305A1 (https=) |
| MX (1) | MXPA06008265A (https=) |
| MY (1) | MY138450A (https=) |
| NO (2) | NO345116B1 (https=) |
| NZ (2) | NZ548351A (https=) |
| PE (1) | PE20050686A1 (https=) |
| PH (1) | PH12019501331A1 (https=) |
| PL (4) | PL3366283T3 (https=) |
| PT (4) | PT3366283T (https=) |
| RS (2) | RS62595B1 (https=) |
| RU (1) | RU2766487C2 (https=) |
| SI (3) | SI3366283T1 (https=) |
| TW (1) | TWI374760B (https=) |
| WO (1) | WO2005067976A2 (https=) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1715893T3 (da) | 2004-01-20 | 2009-11-09 | Novartis Pharma Ag | Direkte kompressionsformulering og fremgangsmåde |
| PL1712547T3 (pl) * | 2004-02-05 | 2012-04-30 | Kyorin Seiyaku Kk | Pochodna bicykloestrowa |
| ES2483126T3 (es) * | 2004-06-17 | 2014-08-05 | Merz Pharma Gmbh & Co. Kgaa | Formulaciones de formas de dosificación de neramexano |
| GT200600008A (es) * | 2005-01-18 | 2006-08-09 | Formulacion de compresion directa y proceso | |
| JP2008024592A (ja) * | 2005-01-28 | 2008-02-07 | Taisho Pharmaceut Co Ltd | シアノピロリジン誘導体含有固形製剤用組成物、それを含有する固形製剤及びその製造方法 |
| AU2006239929B2 (en) | 2005-04-22 | 2011-11-03 | Alantos Pharmaceuticals Holding, Inc. | Dipeptidyl peptidase-IV inhibitors |
| AU2006278039B2 (en) * | 2005-08-11 | 2010-10-21 | F. Hoffmann-La Roche Ag | Pharmaceutical composition comprising a DPP-lV inhibitor |
| BRPI0616694B8 (pt) * | 2005-09-29 | 2021-05-25 | Novartis Ag | processo para preparar comprimido farmacêutico com 80 e 96% em peso com base no peso seco de vildagliptina e metformina ou seus sais farmaceuticamente aceitáveis |
| EA021960B1 (ru) | 2005-12-30 | 2015-10-30 | Крка, Товарна Здравил, Д.Д., Ново Место | Таблетка, содержащая фармацевтически приемлемую соль монтелукаста в аморфной форме, и способ ее получения |
| PT1808164E (pt) * | 2006-01-05 | 2009-03-17 | Teva Pharma | Método de granulação húmida para a preparação de composições farmacêuticas de aripiprazole |
| EP1995237A4 (en) | 2006-03-08 | 2011-07-06 | Kyorin Seiyaku Kk | PROCESS FOR PREPARING AN AMINOACETYLPYRROLIDINCARBONITRILE DERIVATIVE AND PRODUCTION PRODUCT THEREOF |
| ATE488227T1 (de) | 2007-02-01 | 2010-12-15 | Takeda Pharmaceutical | Feste zubereitung mit alogliptin und pioglitazon |
| EP2124901B1 (en) * | 2007-02-01 | 2017-07-19 | Takeda Pharmaceutical Company Limited | Tablet preparation without causing a tableting trouble |
| WO2008104996A2 (en) * | 2007-02-28 | 2008-09-04 | Jubilant Organosys Limited | Water dispersible pharmaceutical formulation and process for preparing the same |
| WO2008114800A2 (en) | 2007-03-13 | 2008-09-25 | Takeda Pharmaceutical Company Limited | Solid preparation comprising 2- [ [6- [ (3r) -3-amino-1-piperidinyl] -3, 4-dihydro-3-methyl-2, 4-dioxo-1 (2h) -pyrimidinyl] methyl] -4-fluorobenzonitrile |
| US8143427B2 (en) | 2007-03-22 | 2012-03-27 | Kyorin Pharmaceutical Co., Ltd. | Method for producing aminoacetylpyrrolidinecarbonitrile derivative |
| PE20090938A1 (es) | 2007-08-16 | 2009-08-08 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| CA2732984A1 (en) | 2008-08-07 | 2010-02-11 | Kyorin Pharmaceutical Co., Ltd. | Process for production of bicyclo[2.2.2]octylamine derivative |
| CN102186474A (zh) * | 2008-08-14 | 2011-09-14 | 杏林制药株式会社 | 稳定的医药组合物 |
| UA119131C2 (uk) | 2008-08-15 | 2019-05-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Похідні пурину для застосування при лікуванні пов'язаних із fab захворювань |
| TW201036975A (en) | 2009-01-07 | 2010-10-16 | Boehringer Ingelheim Int | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy |
| TWI466672B (zh) | 2009-01-29 | 2015-01-01 | Boehringer Ingelheim Int | 小兒科病人糖尿病之治療 |
| UY32427A (es) | 2009-02-13 | 2010-09-30 | Boheringer Ingelheim Internat Gmbh | Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma |
| EP2395988A2 (en) | 2009-02-13 | 2011-12-21 | Boehringer Ingelheim International GmbH | Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics |
| AP2011005795A0 (en) | 2009-02-13 | 2011-08-31 | Boehringer Ingelheim Int | SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia. |
| BRPI1008560B1 (pt) | 2009-02-13 | 2021-08-31 | Boehringer Ingelheim International Gmbh | Composição farmacêutica compreendendo um inibidor de sglt2, um inibidor de dpp-iv e opcionalmente um outro agente antidiabético e usos dos mesmos |
| CN102438617A (zh) | 2009-03-27 | 2012-05-02 | 杏林制药株式会社 | 含有碱性添加剂的基质型缓释制剂 |
| UY32919A (es) | 2009-10-02 | 2011-04-29 | Boehringer Ingelheim Int | Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos |
| KR20240090632A (ko) | 2009-11-27 | 2024-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료 |
| CN102711761B (zh) * | 2009-12-18 | 2015-06-03 | 田边三菱制药株式会社 | 溶出稳定化制剂 |
| US8663661B2 (en) | 2009-12-23 | 2014-03-04 | Ratiopharm Gmbh | Solid pharmaceutical dosage form of ticagrelor |
| JP2013522279A (ja) | 2010-03-18 | 2013-06-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糖尿病及び関連状態の治療で用いるｇｐｒ１１９作動薬とｄｄｐ−ｉｖ阻害薬リナグリプチンの組合せ |
| CA3070513C (en) | 2010-05-05 | 2023-01-03 | Boehringer Ingelheim International Gmbh | A dpp-4 inhibitor for use in treatment of skin-alterations or necrosis |
| KR20130093012A (ko) | 2010-06-24 | 2013-08-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 당뇨병 요법 |
| AR085689A1 (es) | 2011-03-07 | 2013-10-23 | Boehringer Ingelheim Int | Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2 |
| ES2421956B1 (es) | 2012-03-02 | 2014-09-29 | Moehs Ibérica S.L. | Nueva forma cristalina de sulfato de sitagliptina |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| AR092843A1 (es) | 2012-06-05 | 2015-05-06 | Takeda Pharmaceuticals Co | Preparacion solida |
| JP6283316B2 (ja) * | 2012-10-26 | 2018-02-21 | 株式会社三和化学研究所 | アナグリプチン含有固形製剤 |
| EP2769712A1 (en) | 2013-02-21 | 2014-08-27 | Siegfried International AG | Pharmaceutical formulation comprising DPP-IV inhibitor agglomerates and DPP-IV inhibitor particles |
| HRP20190101T1 (hr) | 2013-04-05 | 2019-03-08 | Boehringer Ingelheim International Gmbh | Terapeutske uporabe empagliflozina |
| US11813275B2 (en) | 2013-04-05 | 2023-11-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| US20140303097A1 (en) | 2013-04-05 | 2014-10-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| CA2812519A1 (en) | 2013-04-05 | 2014-10-05 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
| FI4000608T3 (fi) | 2013-04-18 | 2026-01-21 | Boehringer Ingelheim Int | Farmaseuttinen koostumus, menetelmä hoitamiseksi ja sen käyttöjä |
| US20170014380A1 (en) * | 2014-03-06 | 2017-01-19 | Sanovell IIac Sanayi Ve Ticaret Anonim Sirketi | Vildagliptin Formulation Process Under Inert Gas Atmosphere |
| TR201402685A1 (tr) | 2014-03-06 | 2015-09-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Vildagliptinin farmasotik formulasyonları. |
| WO2018050892A1 (en) | 2016-09-16 | 2018-03-22 | Galenicum Health S.L. | Vildagliptin pharmaceutical compositions |
| KR20250097990A (ko) | 2016-11-10 | 2025-06-30 | 베링거 인겔하임 인터내셔날 게엠베하 | 약제학적 조성물, 치료 방법 및 이의 용도 |
| GR1009406B (el) | 2017-10-03 | 2018-11-26 | Φαρματεν Αβεε | Φαρμακευτικο σκευασμα που περιλαμβανει βιλνταγλιπτινη και μεθοδος για την παρασκευη αυτου |
| KR102622198B1 (ko) | 2018-03-30 | 2024-01-09 | 한미약품 주식회사 | 빌다글립틴을 함유하는 경구용 고형제제 및 그의 제조 방법 |
| GR1009644B (el) | 2018-09-25 | 2019-11-12 | Φαρματεν Α.Β.Ε.Ε. | Φαρμακευτικο σκευασμα που περιλαμβανει βιλνταγλιπτινη και μετφορμινη και μεθοδος για την παρασκευη αυτου |
| BE1026818B1 (fr) * | 2018-11-30 | 2020-06-30 | Hedelab Sa | Procede de fabrication d'une serie de n preparations pour complements alimentaires |
| KR102693304B1 (ko) | 2019-04-16 | 2024-08-08 | 한미약품 주식회사 | 빌다글립틴 염산염 함유 복합 제제의 안정성 개선을 위한 포장재 |
| JP7461735B2 (ja) * | 2019-12-02 | 2024-04-04 | 日本ジェネリック株式会社 | ビルダグリプチン含有錠剤 |
| CN113018270A (zh) * | 2019-12-24 | 2021-06-25 | 四川科瑞德制药股份有限公司 | 一种高稳定的盐酸米那普仑制剂及其制备方法 |
| EP4568654A1 (en) * | 2022-08-12 | 2025-06-18 | F. Hoffmann-La Roche AG | Use of co-processed excipients in continuous manufacturing of solid dosage forms |
Family Cites Families (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3131402A1 (de) * | 1981-08-07 | 1983-02-24 | Kilian & Co GmbH, 5000 Köln | Verfahren und tablettenpresse zum aufeinanderfolgenden herstellen einer vielzahl von tabletten mit gleichem gewicht |
| US4894236A (en) * | 1988-01-12 | 1990-01-16 | Choong-Gook Jang | Direct compression tablet binders for acetaminophen |
| DE3833448A1 (de) * | 1988-10-01 | 1990-04-12 | Hoechst Ag | Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung |
| MX9206628A (es) | 1991-11-22 | 1993-05-01 | Boehringer Ingelheim Pharma | Ester de prolinaboronato y metodo para su preparacion. |
| JP3784084B2 (ja) * | 1993-10-21 | 2006-06-07 | 武田薬品工業株式会社 | 医薬用錠剤 |
| IL111785A0 (en) | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
| JP3534130B2 (ja) * | 1994-03-01 | 2004-06-07 | 旭化成ケミカルズ株式会社 | 医薬品組成物 |
| US5543396A (en) | 1994-04-28 | 1996-08-06 | Georgia Tech Research Corp. | Proline phosphonate derivatives |
| DE19616486C5 (de) | 1996-04-25 | 2016-06-30 | Royalty Pharma Collection Trust | Verfahren zur Senkung des Blutglukosespiegels in Säugern |
| WO1998018763A1 (en) | 1996-10-25 | 1998-05-07 | Tanabe Seiyaku Co., Ltd. | Tetrahydroisoquinoline derivatives |
| US6011155A (en) | 1996-11-07 | 2000-01-04 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
| JP4095772B2 (ja) | 1997-11-18 | 2008-06-04 | 財団法人微生物化学研究会 | 新規生理活性物質スルフォスチン、その製造法及びその用途 |
| AU766219B2 (en) | 1998-02-02 | 2003-10-09 | 1149336 Ontario Inc. | Method of regulating glucose metabolism, and reagents related thereto |
| AU3034299A (en) | 1998-03-09 | 1999-09-27 | Fondatech Benelux N.V. | Serine peptidase modulators |
| DE19823831A1 (de) * | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
| DE19828114A1 (de) | 1998-06-24 | 2000-01-27 | Probiodrug Ges Fuer Arzneim | Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV |
| DE19828113A1 (de) | 1998-06-24 | 2000-01-05 | Probiodrug Ges Fuer Arzneim | Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV |
| US6556033B1 (en) | 1998-07-10 | 2003-04-29 | Nhk Spring Co., Ltd. | Electroconductive contact unit assembly |
| US6088938A (en) | 1998-07-17 | 2000-07-18 | Logan; John Duncan | Implement adapter for an excavation tool assembly |
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| US6107317A (en) | 1999-06-24 | 2000-08-22 | Novartis Ag | N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| US6110949A (en) | 1999-06-24 | 2000-08-29 | Novartis Ag | N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
| US6414002B1 (en) | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| EP1228061A4 (en) | 1999-11-12 | 2004-12-15 | Guilford Pharm Inc | DIPEPTIDYL PEPTIDASE IV INHIBITORS; METHODS OF MANUFACTURE AND USE OF SAID INHIBITORS |
| IL149635A0 (en) * | 1999-11-30 | 2002-11-10 | Dainippon Pharmaceutical Co | Solid preparation |
| GB9928330D0 (en) | 1999-11-30 | 2000-01-26 | Ferring Bv | Novel antidiabetic agents |
| PT1741446E (pt) * | 2000-01-21 | 2008-05-09 | Novartis Pharma Ag | Combinações incluindo inibidores da dipeptidilpeptidase-iv e agentes anti-diabéticos |
| AU2001228309A1 (en) | 2000-01-24 | 2001-08-07 | Novo-Nordisk A/S | N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| HU229042B1 (en) | 2000-03-31 | 2013-07-29 | Prosidion Ltd | Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| US6482844B1 (en) | 2000-04-07 | 2002-11-19 | Neurogen Corporation | 1-benzylimidazole derivatives |
| GB0010188D0 (en) | 2000-04-26 | 2000-06-14 | Ferring Bv | Inhibitors of dipeptidyl peptidase IV |
| GB0010183D0 (en) | 2000-04-26 | 2000-06-14 | Ferring Bv | Inhibitors of dipeptidyl peptidase IV |
| GB0014969D0 (en) | 2000-06-19 | 2000-08-09 | Smithkline Beecham Plc | Novel method of treatment |
| WO2002002560A2 (en) | 2000-07-04 | 2002-01-10 | Novo Nordisk A/S | Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv) |
| US7074794B2 (en) | 2000-08-10 | 2006-07-11 | Mitsubishi Pharma Corporation | Proline derivatives and the use thereof as drugs |
| CA2424770A1 (en) * | 2000-10-06 | 2003-04-03 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation |
| US7138397B2 (en) | 2000-10-06 | 2006-11-21 | Tanabe Seiyaku Co., Ltd. | Nitrogenous 5-membered ring compounds |
| TWI243162B (en) | 2000-11-10 | 2005-11-11 | Taisho Pharmaceutical Co Ltd | Cyanopyrrolidine derivatives |
| WO2002053548A1 (fr) | 2000-12-27 | 2002-07-11 | Banyu Pharmaceutical Co.,Ltd. | Derives de la benzothiazepine |
| WO2002051836A1 (en) | 2000-12-27 | 2002-07-04 | Kyowa Hakko Kogyo Co., Ltd. | Dipeptidyl peptidase iv inhibitor |
| CN1500080A (zh) | 2001-02-02 | 2004-05-26 | ����ҩƷ��ҵ��ʽ���� | 稠合杂环化合物 |
| WO2002066627A1 (en) | 2001-02-16 | 2002-08-29 | Bayer Aktiengesellschaft | Regulation of human dipeptidyl peptidase 8 |
| KR100926247B1 (ko) | 2001-02-24 | 2009-11-12 | 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 | 크산틴 유도체를 포함하는 약제학적 조성물 및 이의제조방법 |
| WO2002067918A1 (en) | 2001-02-27 | 2002-09-06 | Banyu Pharmaceutical Co., Ltd. | Novel diallylmethylamine derivative |
| ATE395912T1 (de) | 2001-03-27 | 2008-06-15 | Merck & Co Inc | Dipeptidylpeptidase-hemmer für die behandlung oder prävention von diabetes |
| FR2822826B1 (fr) | 2001-03-28 | 2003-05-09 | Servier Lab | Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB0109146D0 (en) | 2001-04-11 | 2001-05-30 | Ferring Bv | Treatment of type 2 diabetes |
| US6573287B2 (en) | 2001-04-12 | 2003-06-03 | Bristo-Myers Squibb Company | 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method |
| WO2002088090A2 (en) | 2001-04-27 | 2002-11-07 | Vertex Pharmaceuticals Incorporated | Pyrazole derived kinase inhibitors |
| FR2824825B1 (fr) | 2001-05-15 | 2005-05-06 | Servier Lab | Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US20030060494A1 (en) | 2001-05-18 | 2003-03-27 | Nobuyuki Yasuda | Pharmaceutical use of N-carbamoylazole derivatives |
| SE523510C2 (sv) | 2001-05-18 | 2004-04-27 | Jan G Faeger | Förfarande för att fastställa en varelses position och/eller orientering i förhållande till en omgivning |
| ES2257555T3 (es) | 2001-06-20 | 2006-08-01 | MERCK & CO., INC. | Inhibidores de dipeptidilpeptidasa para el tratamiento de la diabetes. |
| EP1406872B1 (en) | 2001-06-20 | 2007-12-19 | Merck & Co., Inc. | Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| GB0115517D0 (en) | 2001-06-25 | 2001-08-15 | Ferring Bv | Novel antidiabetic agents |
| DE60221983T2 (de) | 2001-06-27 | 2008-05-15 | Smithkline Beecham Corp. | Fluorpyrrolidine als dipeptidyl-peptidase inhibitoren |
| RU2299066C2 (ru) | 2001-06-27 | 2007-05-20 | Пробиодруг Аг | Новые ингибиторы дипептидилпептидазы iv и их применение в качестве противораковых агентов |
| ES2296979T3 (es) | 2001-06-27 | 2008-05-01 | Smithkline Beecham Corporation | Fluoropirrolidinas como inhibidores de dipeptidil peptidasa. |
| US20030005443A1 (en) | 2001-06-27 | 2003-01-02 | Karin Axelsson | EPG having PIP window history and sample view functionality |
| WO2003003250A1 (en) | 2001-06-28 | 2003-01-09 | Hywire Ltd. | Range content-addressable memory |
| WO2003004496A1 (en) | 2001-07-03 | 2003-01-16 | Novo Nordisk A/S | Dpp-iv-inhibiting purine derivatives for the treatment of diabetes |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| WO2003024942A1 (en) | 2001-09-14 | 2003-03-27 | Mitsubishi Pharma Corporation | Thiazolidine derivative and medicinal use thereof |
| EP1463727A2 (en) | 2001-09-19 | 2004-10-06 | Novo Nordisk A/S | Heterocyclic compounds that are inhibitors of the enzyme dpp-iv |
| SE0103424D0 (sv) | 2001-10-15 | 2001-10-15 | Astrazeneca Ab | Pharmaceutical formulation |
| GB0125446D0 (en) | 2001-10-23 | 2001-12-12 | Ferring Bv | Novel anti-diabetic agents |
| GB0125445D0 (en) | 2001-10-23 | 2001-12-12 | Ferring Bv | Protease Inhibitors |
| US6861440B2 (en) | 2001-10-26 | 2005-03-01 | Hoffmann-La Roche Inc. | DPP IV inhibitors |
| MXPA04006780A (es) * | 2002-01-11 | 2005-06-08 | Athpharma Ltd | Formulaciones farmaceuticas de pravastatina y metodos para usarlas. |
| JP2005513165A (ja) | 2002-01-11 | 2005-05-12 | ノボ ノルディスク アクティーゼルスカブ | 糖尿病、高血圧、慢性心不全および体液貯留状態の治療のための方法および組成物 |
| KR100608414B1 (ko) | 2002-02-13 | 2006-08-02 | 에프. 호프만-라 로슈 아게 | 신규한 피리딘- 및 피리미딘-유도체 |
| HUP0200849A2 (hu) | 2002-03-06 | 2004-08-30 | Sanofi-Synthelabo | N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra |
| BR0308816A (pt) | 2002-04-08 | 2005-03-22 | Torrent Pharmaceuticals Ltd | Tiazolidina-4-carbonitrilas e análogos e seus usos como inibidores da dipeptil-peptidas |
| JP2003327532A (ja) | 2002-05-10 | 2003-11-19 | Takeda Chem Ind Ltd | ペプチダーゼ阻害剤 |
| CN100402026C (zh) | 2002-06-03 | 2008-07-16 | 诺瓦提斯公司 | 取代的氰基吡咯烷和含有它们的组合制剂用于治疗高脂血症和相关疾病的用途 |
| WO2004024184A1 (ja) | 2002-09-11 | 2004-03-25 | Takeda Pharmaceutical Company Limited | 徐放性製剤 |
| KR20050067418A (ko) | 2002-10-18 | 2005-07-01 | 머크 앤드 캄파니 인코포레이티드 | 당뇨병을 치료 또는 예방하기 위한 베타-아미노헤테로사이클릭 디펩티딜 펩티다제 억제제 |
| DE60332856D1 (de) | 2002-10-23 | 2010-07-15 | Bristol Myers Squibb Co | Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv |
| DE10256264A1 (de) | 2002-12-03 | 2004-06-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Imidazo-pyridinone und Imidazo-pyridazinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US7420079B2 (en) | 2002-12-09 | 2008-09-02 | Bristol-Myers Squibb Company | Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof |
| WO2004071454A2 (en) | 2003-02-13 | 2004-08-26 | Guilford Pharmaceuticals Inc. | Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv |
| AU2003207881A1 (en) | 2003-02-28 | 2004-09-17 | Aic | Dipeptidyl peptidase inhibitors |
| US20040186046A1 (en) * | 2003-03-17 | 2004-09-23 | Pfizer Inc | Treatment of type 1 diabetes with PDE5 inhibitors |
| PE20081293A1 (es) | 2003-04-16 | 2008-11-04 | Novartis Ag | Procedimiento de preparacion de compuestos 2(s)-cianopirrolidina n-(n'-glicilo sustituida) |
| DK1715893T3 (da) | 2004-01-20 | 2009-11-09 | Novartis Pharma Ag | Direkte kompressionsformulering og fremgangsmåde |
| AR050615A1 (es) | 2004-08-27 | 2006-11-08 | Novartis Ag | Composiciones farmaceuticas para la administracion oral |
-
2005
- 2005-01-17 DK DK05700976T patent/DK1715893T3/da active
- 2005-01-17 CA CA2552569A patent/CA2552569C/en not_active Expired - Lifetime
- 2005-01-17 SI SI200532299T patent/SI3366283T1/sl unknown
- 2005-01-17 DE DE602005015421T patent/DE602005015421D1/de not_active Expired - Lifetime
- 2005-01-17 EP EP18165545.7A patent/EP3366283B1/en not_active Expired - Lifetime
- 2005-01-17 PL PL18165545T patent/PL3366283T3/pl unknown
- 2005-01-17 ES ES20177506T patent/ES2940341T3/es not_active Expired - Lifetime
- 2005-01-17 WO PCT/EP2005/000400 patent/WO2005067976A2/en not_active Ceased
- 2005-01-17 LT LTEP15199440.7T patent/LT3023095T/lt unknown
- 2005-01-17 ES ES05700976T patent/ES2332920T3/es not_active Expired - Lifetime
- 2005-01-17 PT PT181655457T patent/PT3366283T/pt unknown
- 2005-01-17 US US10/586,059 patent/US20080038341A1/en not_active Abandoned
- 2005-01-17 ES ES15199440T patent/ES2684325T5/es not_active Expired - Lifetime
- 2005-01-17 LT LTEP18165545.7T patent/LT3366283T/lt unknown
- 2005-01-17 RS RS20211399A patent/RS62595B1/sr unknown
- 2005-01-17 EP EP15199440.7A patent/EP3023095B2/en not_active Expired - Lifetime
- 2005-01-17 JP JP2006549999A patent/JP5122144B2/ja not_active Expired - Lifetime
- 2005-01-17 PL PL05700976T patent/PL1715893T3/pl unknown
- 2005-01-17 PL PL20177506.1T patent/PL3738585T3/pl unknown
- 2005-01-17 NZ NZ548351A patent/NZ548351A/xx not_active IP Right Cessation
- 2005-01-17 PL PL15199440T patent/PL3023095T3/pl unknown
- 2005-01-17 RS RS20180946A patent/RS57561B1/sr unknown
- 2005-01-17 PT PT15199440T patent/PT3023095T/pt unknown
- 2005-01-17 RU RU2006130009A patent/RU2766487C2/ru active
- 2005-01-17 HU HUE18165545A patent/HUE056586T2/hu unknown
- 2005-01-17 SI SI200530794T patent/SI1715893T1/sl unknown
- 2005-01-17 EP EP20090157626 patent/EP2165703A3/en not_active Withdrawn
- 2005-01-17 EP EP20177506.1A patent/EP3738585B1/en not_active Revoked
- 2005-01-17 DK DK18165545.7T patent/DK3366283T3/da active
- 2005-01-17 KR KR1020067014506A patent/KR101259645B1/ko not_active Expired - Fee Related
- 2005-01-17 BR BR122018014389-4A patent/BR122018014389B1/pt active IP Right Grant
- 2005-01-17 HR HRP20211766TT patent/HRP20211766T1/hr unknown
- 2005-01-17 BR BR122018073405-1A patent/BR122018073405B1/pt active IP Right Grant
- 2005-01-17 MX MXPA06008265A patent/MXPA06008265A/es active IP Right Grant
- 2005-01-17 HU HUE15199440A patent/HUE039902T2/hu unknown
- 2005-01-17 BR BRPI0507007-4A patent/BRPI0507007A/pt not_active Application Discontinuation
- 2005-01-17 EP EP05700976A patent/EP1715893B8/en not_active Revoked
- 2005-01-17 NZ NZ578743A patent/NZ578743A/en not_active IP Right Cessation
- 2005-01-17 ES ES18165545T patent/ES2899417T3/es not_active Expired - Lifetime
- 2005-01-17 SI SI200532218T patent/SI3023095T1/sl unknown
- 2005-01-17 PT PT201775061T patent/PT3738585T/pt unknown
- 2005-01-17 DK DK15199440.7T patent/DK3023095T3/en active
- 2005-01-17 PT PT05700976T patent/PT1715893E/pt unknown
- 2005-01-17 AU AU2005205055A patent/AU2005205055B2/en not_active Ceased
- 2005-01-19 MY MYPI20050199A patent/MY138450A/en unknown
- 2005-01-19 AR ARP050100182A patent/AR049000A1/es not_active Application Discontinuation
- 2005-01-19 TW TW094101577A patent/TWI374760B/zh not_active IP Right Cessation
- 2005-01-19 PE PE2005000075A patent/PE20050686A1/es not_active Application Discontinuation
-
2006
- 2006-07-13 IL IL176831A patent/IL176831A0/en active IP Right Review Request
- 2006-07-18 EC EC2006006707A patent/ECSP066707A/es unknown
- 2006-07-24 MA MA29205A patent/MA28305A1/fr unknown
- 2006-08-21 NO NO20063739A patent/NO345116B1/no unknown
-
2009
- 2009-10-14 CY CY20091101062T patent/CY1110522T1/el unknown
-
2011
- 2011-06-06 US US13/154,063 patent/US20110236479A1/en not_active Abandoned
- 2011-08-04 EC EC2011006707A patent/ECSP11006707A/es unknown
-
2012
- 2012-05-09 JP JP2012107450A patent/JP5739835B2/ja not_active Expired - Lifetime
- 2012-07-31 US US13/562,415 patent/US20120294939A1/en not_active Abandoned
-
2014
- 2014-03-27 US US14/226,871 patent/US20140205663A1/en not_active Abandoned
-
2018
- 2018-08-03 HR HRP20181270TT patent/HRP20181270T1/hr unknown
- 2018-08-10 CY CY20181100840T patent/CY1120575T1/el unknown
- 2018-11-29 EC ECSENADI201889087A patent/ECSP18089087A/es unknown
-
2019
- 2019-06-13 PH PH12019501331A patent/PH12019501331A1/en unknown
-
2020
- 2020-08-10 NO NO20200892A patent/NO20200892A1/no unknown
-
2021
- 2021-11-29 CY CY20211101034T patent/CY1124770T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007518760A5 (https=) | ||
| CA2552569A1 (en) | Direct compression formulation and process | |
| KR100696350B1 (ko) | 급속 방출 정제 | |
| US20090186086A1 (en) | Solid multilayer oral dosage forms | |
| JP5622575B2 (ja) | 固形バルサルタン組成物 | |
| CA2501659A1 (en) | Deferasirox dispersible tablets | |
| CA2688721A1 (en) | Stable pharmaceutical formulation for a dpp-iv inhibitor | |
| SK284049B6 (sk) | Orálny prostriedok a spôsob jeho prípravy | |
| CN101219120B (zh) | 替米沙坦分散片及其制备方法 | |
| TW202139977A (zh) | 包括阿托伐他汀以及怡妥錠的雙層片劑及其製造方法 | |
| US20120107397A1 (en) | Pharmaceutical compositions of valsartan | |
| EP3793529A1 (en) | Stable pharmaceutical compositions of dpp-iv inhibitors in combination with metformin in the form of immediate release tablets | |
| WO2018211479A1 (en) | Stabilized compositions of angiotensin ii inhibitors and neutral endopeptidase inhibitors and process for preparation thereof | |
| US9592202B2 (en) | Method to stabilize a dietary supplement to facilitate joint health in humans | |
| WO2010120963A1 (en) | Tablet formulation for p38 inhibitor and method | |
| WO2010057449A2 (en) | A solid pharmaceutical composition with atorvastatin and telmisartan as the active substances | |
| WO2000071117A1 (en) | Immediate release medicinal compositions for oral use | |
| US20080008751A1 (en) | Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof | |
| JP5113476B2 (ja) | 保存安定性に優れた塩酸テモカプリルの錠剤 | |
| JP5286662B2 (ja) | 安中散含有錠剤 | |
| CA2379887C (en) | Stable tablets comprising simvastatin | |
| RU2007147949A (ru) | Композиция, содержащая ингибиторы dpp-iv глитазоны, полученная прямым прессованием, и способ ее получения | |
| CN102028670A (zh) | 一种包含替米沙坦和钙离子通道拮抗剂的复方胶囊剂 | |
| US20030229101A1 (en) | Tablets comprising ciprofloxacin hydrochloride | |
| JP2022139865A (ja) | 錠剤 |